The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Mobile COVID-19 testing is being evaluated using the
Company’s q16 instrument combined with its ExsigTM Direct
reagent. Trials in clinical laboratories are expected to complete
by the end of July 2020 and, subject to validation, this
combination will initially be used in remote locations, such as
care homes.
The Group’s core reagent products are based on molecular
and protein diagnostic technologies and an extensive
product catalogue generates sales from clinical testing,
food testing and animal testing diagnostics. The Group will
continue to invest in commercial infrastructure for its clinical
and food sales channels.
In 2019, core reagent sales across the Group grew by
3% year-on-year, with Primerdesign delivering 8% growth
in reagent revenues from €5.6m (£5.0m) in 2018 to
€6.1m (£5.4m) in 2019. Primerdesign also achieved 12%
international revenue growth from €4.1m (£3.6m) in 2018 to
€4.7m (£4.1m) in 2019, despite restricted q16 instrument sales due to lack of stock. This strong international
performance was largely offset by weaker sales in the
smaller UK direct market (down 13%) following the shortterm impact of restructuring the commercial team in the
second quarter of 2019.
Microgen Bioproducts sales, part of the Lab21 business,
were also robust despite the continued stock shortages,
as demonstrated by UK and Ireland direct sales increasing
by 13% and Middle East sales increasing by 8% on the
prior year.
The Company started 2020 with an order book significantly
higher than at the same time last year. Lab21 had confirmed
orders of over €1.5m at the end of the year. Of these orders,
€1m could not be delivered due to working capital and
supply chain issues. The Group expects to fully restore
manufacturing output and stock levels to normal during
2020 to meet this demand.
gggg21, responding to what you just said regarding NCYT " i share with loyal novacyt holders who have been here since feb like me" , guess what I have been in NCYT, looks like you have not been here longer than me and probably do not hold as many shares as I do.
Anyways best of luck to all.
Old news....
"" Post from ADVFN;
“Company have confirmed partnerships have been agreed and RNS should be released next week.”
If correct then news will be sooner than previously thought. Good news ""
ADVFN LINK.....
Where is the link ???
https://uk.news.yahoo.com/coronavirus-south-korea-second-wave-112229586.html
This one may be one of them....
https://www.proactiveinvestors.co.uk/companies/news/922359/catenae-innovation-focused-on-commercialising-cov-id-app-after-positive-proof-of-concept-trial-922359.html
https://www.share-talk.com/share-talk-bulletin-board-heroes-thursday-18th-june-2020/#gs.8c7lvv
Go to where says Regular Share Chat....Premium Share Chat... then FILTERS.
There you just filter him and you don't have to deal or read his crap.
FILTER HIM
For COVID-Passport....
Catenae Innovation: Primed for the new COVID reality
More info about COVID-Passports...
https://www.proactiveinvestors.co.uk/companies/news/918879/catenae-innovation-primed-for-the-new-covid-reality-918879.html
This is very interesting to read...
Is this one of the potential apps ???
https://cov-id.io/#challenges
More MM's codes....
https://falconstocks.com/articles/readingmarketmakers.htm
Something about MM's wanting shares
https://falconstocks.com/articles/readingmarketmakers.html
Filter them and that's the end of their non sense
THIS IS WHAT Velo POST about....
" . . . I'm intrigued to see if it closes the next Gap which is stationed just below 220 up to 250-ish, and leaves me wondering is that where this downtrend is heading, if it doesn't disintegrate next week, and return to the uptrend?
Below that is the largest Gap up of them all - but I won't even mention it, as it just looks horrendously unfeasible. "
(I left that last sentence in, as the third of the three Gap-up's is by far the largest of them all, but is so far down, I dare not post it's values until the second gap-up closes. Don't think that huge third gap-up will be visited on this run. Something mighty would need to occur first, so could be waiting a long time - if it ever closes at all).
- No Cabert, the Gap did not close today and still remains an unclosed festering sore, but with tonight's close it's definitely on the cards from tomorrow onwards. (Sometimes they can take numerous visits to complete). And the down trend is still aggressively bearish
The price did knock on the door and commenced entry getting as far as mid 230's, but to actually reach the lower level today would have been faster and further than my expectations.
To be clear, I'm seeing circa 217-ish as the lower level and 252 as the upper level of the Gap, so the SP definitely made an incursion into that area. Now, will it go on to close that gap and visit 217 ?
After which I'd be looking for bullish signs that the raid was over and pick an entry point (or top-up point if already holding).
- But a bit of perspective, and for that I'm just going to lift and copy paste from that post to save re-typing:
" . . . it has to be borne in mind that although the short term trend is currently still in a bearish retrace - the medium and near 'long' term trends are all visibly and strongly bullish. And the longer term sentiment trends always rule - as all lesser trends are merely waves within cycles and zig-zags within a larger wave and that is - that the medium to longer term trend in NCYT is still bullish. . . "
Cloudstrife is a clown that should be filter by everybody and I normally don't filter people.
If you guys notice he has open this account on 6th Jun 2020 and has more NEGATIVE post in this short time that people that have been here for much longer time.
This clown is a troll that doesn't offer any valuable information in any of this post in any BB.
GLA